# China NMPA Inspection - Tonghua Changyuan Pharmaceutical Technology Co., Ltd. - August 20, 2019

Source: https://www.globalkeysolutions.net/records/china_inspection/tonghua-changyuan-pharmaceutical-technology-co-ltd/7f0b8790-fbe4-49f8-924f-64a990e2f7c6/
Source feed: China

> China NMPA unannounced inspection for Tonghua Changyuan Pharmaceutical Technology Co., Ltd. published August 20, 2019. The Jilin Provincial Drug Administration announced on August 20, 2019, its proposal to issue a Cosmetic Production License to Tonghua Changyuan Pharma

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Jilin Provincial Drug Administration's Notice on the Proposed Issuance of Cosmetic Production Licenses (No. 2 of 2019)
- Company Name: Tonghua Changyuan Pharmaceutical Technology Co., Ltd.
- Publication Date: 2019-08-20
- Product Type: Cosmetics
- Summary: The Jilin Provincial Drug Administration announced on August 20, 2019, its proposal to issue a Cosmetic Production License to Tonghua Changyuan Pharmaceutical Technology Co., Ltd. This significant regulatory step followed a thorough on-site inspection, meticulously conducted by the administration to ensure compliance with the requirements outlined in the former State Food and Drug Administration's "Notice on Further Improving Current Work Related to Cosmetic Production Licensing." The inspection, which took place prior to the announcement, concluded with approval for the company, indicating that no significant violations or issues were identified that would impede its licensure. The proposed license will authorize Tonghua Changyuan Pharmaceutical Technology Co., Ltd., located at No. 88, Baoan Road, Xinzhan Street, Tonghua City, to produce cosmetics within the scope of Powder Unit (Loose Powder). Key personnel involved in the company's operations include Xu Baohua, who holds positions as both Legal Representative and Company Head, and Ge Yunfei, who is responsible for quality assurance as the Quality Head. As a final procedural step, the relevant information regarding this proposed license issuance has been publicized for a period of 5 working days. This public disclosure allows for community oversight and welcomes public supervision, ensuring transparency in the regulatory process before the final license is officially granted. This process underscores the administration's commitment to consumer safety and product quality in the cosmetic industry.

Company: https://www.globalkeysolutions.net/companies/tonghua-changyuan-pharmaceutical-technology-co-ltd/59073268-9572-430a-ab11-da3e868f901f/